Deep Dive: Is Medline the Costco of Healthcare? Inside the Biggest IPO of 2025
December 20, 2025
AI Summary
5 min read🎙️ The Voices & The Context
- The Format: This solo-hosted deep dive podcast episode delivers a structured financial breakdown of Medline's blockbuster 2025 IPO, blending historical narrative with analytical insights into its business dominance in medical supplies. Analytical and enthusiastic.
- The Format: A narrative story driven by a single host's monologue.
- The Key Players:
- If Just Hosts: Solo host from "The Rundown" delivers a high-energy, fact-packed rundown with infectious excitement for uncovering hidden gems in boring industries, bantering lightly with the audience about investment hype.
🗝️ Key Themes & Topics
The episode unpacks Medline's rise as the largest IPO of 2025 despite its unglamorous medical supplies business, highlighting its Costco-like model, unstoppable growth, and looming risks amid a hot IPO market featuring names like Circle and Klarna.
- Topic 1: Medline's History and Path to IPO. The host traces the company's 50-year journey from 1966 founding by brothers Jim and John Mills, its brief 1972 public stint that they quickly reversed to go private, a massive 2021 $34 billion private equity buyout loading it with debt, and its 2025 relaunch raising $6.3 billion at $29/share under ticker MDLN, surging 40% on day one to a $50 billion market cap—the biggest since Rivian.
- Topic 2: Costco-Like Business Model. CEO Jim Boyl
Continue reading the full summary in the app — free to try.
Read Full Summary →Free • No credit card required
What you'll learn
- 1 (00:00) **Episode Introduction: Medline's Record-Breaking IPO**
- 2 (01:00) **Medline's Company History**
- 3 (02:04) **Medline's 2025 IPO Details and Market Reception**
- 4 (02:50) **CEO's Vision: Medline as the "Costco of Healthcare"**
- 5 (04:18) **Core Business Strengths: Products and Distribution Moat**
- 6 (04:55) **Bull Case: Consistent Growth and Resilience**
- 7 (07:01) **Bear Case: Key Risks and Headwinds**
+ Full timestamped outline available in the app
Show Notes
Medline just pulled off the biggest IPO of 2025, beating out higher-profile names like Circle, Klarna, and Figma despite being a company most people have never heard of. In this episode, we break down how this family-owned medical-supply giant built a massive moat, why its CEO calls it the “Costco of Healthcare,” and the risks investors should be watching.
More from this podcast
The Rundown →